Posted on July 18th, 2009 by Health News
Treating patients with thalidomide in combination with chemotherapy for small cell lung cancer (SCLC) did not improve their survival but did increase their risk of blood clots, according to a new study published online July 16 in the Journal of the National Cancer Institute.
Read more
Filed under: Pharmacy News
Tags: cancer, Online, Pharmacy
Related posts
- ZEN bust-enhancing supplements may increase risk of breast cancer (0)
Women who use bust-enhancing dietary supplements containing the mycoestrogen zearalenone (ZEN), a naturally occurring toxin that widely contaminates agricultural products, could be increasing their risk of breast cancer. That is the warning from breast health experts in a paper published online ahead of print publication in the January issue of IJCP, the International Journal of [...]
- When To Administer Food And Drugs Together (0)
A regulatory bias against taking oral anti-cancer medications with food places many patients at increased risk for an overdose and forces them to "flush costly medicines down the toilet," argues Mark Ratain, MD, an authority on cancer-drug dosing. In a commentary published early online Sept. 19 in the Journal of Clinical Oncology, Ratain, the Leon [...]
- Two-drug combination destroys precancerous colon polyps (0)
A two-drug combination destroys precancerous colon polyps with no effect on normal tissue, opening a new potential avenue for chemoprevention of colon cancer, a team of scientists at The University of Texas M. D. Anderson Cancer Center reports in the advance online edition of the journal Nature.
Read more
[tags] Pharmacy News [/tags]
- Two Pivotal Vectibix® Phase 3 Studies In First And Second-Line Treatment Of Metastatic Colorectal Cancer (0)
Amgen (Nasdaq: AMGN) announced that results from the PRIME '203' and '181' pivotal Phase 3 trials evaluating Vectibix® (panitumumab) in combination with chemotherapy (FOLFOX or FOLFIRI) as a first and second-line treatment for metastatic colorectal cancer (mCRC), respectively, were published online in the Journal of Clinical Oncology...
Read more
[tags] Pharmacy News [/tags]
- Tamoxifen against breast cancer can save lives and reduce medical costs (0)
Tamoxifen, taken by certain women as a preventive measure against breast cancer, saves lives and reduces medical costs. That is the conclusion of a new study published early online in CANCER, a peer-reviewed journal of the American Cancer Society.
Read more
[tags] Pharmacy News [/tags]
Leave a Reply